Breaking News
Get 45% Off 0
Selloff or market correction? Either way, here's what to do next
See Overvalued Stocks

Stock Markets Analysis & Opinion

Contribute
Zacks Investment Research
Five Reasons To Buy AMD (AMD) Ahead Of Earnings   By Zacks Investment Research - Jan 29, 2018

On Tuesday, January 30th, Advanced Micro Devices (NASDAQ:AMD) will release its fourth quarter earnings results after the bell. The company is a Zacks Rank 3 (Hold), and have a Value, Growth, and...

Zacks Investment Research
3 Minnesota Stocks To Buy Ahead Of Super Bowl LII By Zacks Investment Research - Jan 29, 2018

A week out from Super Bowl LII in Minneapolis, with much of the football world beginning to descend upon Minnesota, businesses around the Twin Cities hope to experience an economic boost.Estimates...

Zacks Investment Research
ECB Meeting Puts These Euro ETFs In Focus By Zacks Investment Research - Jan 29, 2018

The European Central Bank (ECB) kept interest rates unchanged and indicated that “they expect borrowing costs to stay at present levels until well past the end of net bond purchases.” The...

Zacks Investment Research
Coal Industry Outlook - January 2018 By Zacks Investment Research - Jan 29, 2018

The U.S. coal industry has faced stringent environmental regulations over the last few years. However, conditions have started to change for the better after the election of the Trump administration,...

Zacks Investment Research
AMD's Q4 Earnings To Benefit From Strong Demand For GPU By Zacks Investment Research - Jan 29, 2018

Advanced Micro Devices (NASDAQ:AMD) is set to report fourth-quarter 2017 results on Jan 30. The company is expected to gain from robust demand of graphic processor unit (GPU), which is now profusely...

Zacks Investment Research
Malaysia ETFs In Focus On Interest Rate Hike By Zacks Investment Research - Jan 29, 2018

Malaysia’s central bank, Bank Negara Malaysia, hiked its key interest rate for the first time since July 2014. The move was largely expected, as 16 out of 20 economists surveyed by Bloomberg...

Zacks Investment Research
3 Key Estimates For Microsoft's Q3 Earnings Report By Zacks Investment Research - Jan 29, 2018

Shares of Microsoft (NASDAQ:MSFT) were relatively flat on Monday, just two days before what could prove to be another pivotal moment in company history. The technology behemoth is slated to announce...

Zacks Investment Research
3 Growth Stocks To Watch This Earnings Season By Zacks Investment Research - Jan 29, 2018

It’s perhaps the only downside to an eight-year bull market that’s still hitting new highs with no end in sight: How do you find growth in an environment like this? You could wait for one...

Trade12
Can Pfizer Beat Analysts’ Forecasts? By Trade12 - Jan 29, 2018

The all-American pharmaceutical company, Pfizer (NYSE:PFE), is looking to report its fourth-quarter and full year 2017 results next week and here are the things that you can expect from the company....

Zacks Investment Research
Telecom Stocks Earnings Roster For Jan 30: HRS, GLW & JNPR By Zacks Investment Research - Jan 29, 2018

The earnings season has already started and the picture, so far, appears to be encouraging. Per the Earnings Preview dated Jan 26, nearly 133 of the S&P 500 members have reported their results....

Zacks Investment Research
FANG's Must-See Earnings Charts   By Zacks Investment Research - Jan 29, 2018

This is the week that investors love. Even though it’s not the busiest week in earnings season, with just about 400 companies reporting, it includes some of the biggest, most glamorous...

Zacks Investment Research
Industrials ETFs In Focus On Q4 Earnings By Zacks Investment Research - Jan 29, 2018

The earnings season is off to a flying start with equity markets scaling record highs, owing to a slew of upbeat economic data, strong corporate performance and President Donald Trump's tax reform...

Zacks Investment Research
Novartis' Lutathera Gets FDA Approval For Pancreatic Tumors By Zacks Investment Research - Jan 29, 2018

Novartis AG’s (NYSE:NVS) subsidiary, Advanced Accelerator Applications, obtained FDA approval for its new drug application (NDA) for Lutathera (lutetium Lu 177 dotatate) for the treatment of...

Zacks Investment Research
Top Stock Picks For The Week Of Jan 29, 2018   By Zacks Investment Research - Jan 29, 2018

Caterpillar Inc. (NYSE:CAT) recently kept its great 5-year earnings streak alive as it beat fourth quarter estimates by 22%. The construction and mining equipment maker is expected to grow earnings...

Continue with Apple
Continue with Google
or
Sign up with Email